{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:49:06Z","timestamp":1773874146854,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,2,16]],"date-time":"2013-02-16T00:00:00Z","timestamp":1360972800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Natural products are considered a rich source of new chemical structures that may lead to the therapeutic agents in all major disease areas. About 50% of the drugs introduced in the market in the last 20 years were natural products\/derivatives or natural products mimics, which clearly shows the influence of natural products in drug discovery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In an effort to further support the research in this field, we have developed an integrative knowledge base on Marine Sponge Compounds Interactions (Dragon Exploration System on Marine Sponge Compounds Interactions - DESMSCI) as a web resource. This knowledge base provides information about the associations of the sponge compounds with different biological concepts such as human genes or proteins, diseases, as well as pathways, based on the literature information available in PubMed and information deposited in several other databases. As such, DESMSCI is aimed as a research support resource for problems on the utilization of marine sponge compounds. DESMSCI allows visualization of relationships between different chemical compounds and biological concepts through textual and tabular views, graphs and relational networks. In addition, DESMSCI has built in hypotheses discovery module that generates potentially new\/interesting associations among different biomedical concepts. We also present a case study derived from the hypotheses generated by DESMSCI which provides a possible novel mode of action for variolins in Alzheimer\u2019s disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>DESMSCI is the first publicly available (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.cbrc.kaust.edu.sa\/desmsci\" ext-link-type=\"uri\">http:\/\/www.cbrc.kaust.edu.sa\/desmsci<\/jats:ext-link>) comprehensive resource where users can explore information, compiled by text- and data-mining approaches, on biological and chemical data related to sponge compounds.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1758-2946-5-11","type":"journal-article","created":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T15:44:13Z","timestamp":1361202253000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Dragon exploration system on marine sponge compounds interactions"],"prefix":"10.1186","volume":"5","author":[{"given":"Sunil","family":"Sagar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandar","family":"Radovanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir B","family":"Bajic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,16]]},"reference":[{"key":"450_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1039\/a902202c","volume":"17","author":"DJ Newman","year":"2000","unstructured":"Newman DJ, Cragg GM, Snader KM: The influence of natural products upon drug discovery. Nat Prod Rep. 2000, 17: 215-234. 10.1039\/a902202c.","journal-title":"Nat Prod Rep"},{"key":"450_CR2","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1021\/np030096l","volume":"66","author":"DJ Newman","year":"2003","unstructured":"Newman DJ, Cragg GM, Snader KM: Natural products as sources of new drugs over the period 1981\u20132002. J Nat Prod. 2003, 66: 1022-1037. 10.1021\/np030096l.","journal-title":"J Nat Prod"},{"key":"450_CR3","doi-asserted-by":"publisher","first-page":"E239","DOI":"10.1007\/BF02854894","volume":"8","author":"YW Chin","year":"2006","unstructured":"Chin YW, Balunas MJ, Chai HB, Kinghorn AD: Drug discovery from natural sources. AAPS J. 2006, 8: E239-E253.","journal-title":"AAPS J"},{"key":"450_CR4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nrd1657","volume":"4","author":"FE Koehn","year":"2005","unstructured":"Koehn FE, Carter GT: The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 2005, 4: 206-220. 10.1038\/nrd1657.","journal-title":"Nat Rev Drug Discov"},{"key":"450_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1126\/science.1116364","volume":"310","author":"I Paterson","year":"2005","unstructured":"Paterson I, Anderson EA: Chemistry, The renaissance of natural products as drug candidates. Science. 2005, 310: 451-453. 10.1126\/science.1116364.","journal-title":"Science"},{"key":"450_CR6","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1016\/j.bmc.2005.05.067","volume":"13","author":"M Tulp","year":"2005","unstructured":"Tulp M, Bohlin L: Rediscovery of known natural compounds: nuisance or goldmine?. Bioorg Med Chem. 2005, 13: 5274-5282. 10.1016\/j.bmc.2005.05.067.","journal-title":"Bioorg Med Chem"},{"key":"450_CR7","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.2174\/0929867043365116","volume":"11","author":"P Vuorelaa","year":"2004","unstructured":"Vuorelaa P, Leinonenb M, Saikkuc P, Tammelaa P, Rauhad JP, Wennberge T, Vuorela H: Natural products in the process of finding new drug candidates. Curr Med Chem. 2004, 11: 1375-1389. 10.2174\/0929867043365116.","journal-title":"Curr Med Chem"},{"key":"450_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1021\/np068054v","volume":"70","author":"DJ Newman","year":"2007","unstructured":"Newman DJ, Cragg GM: Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007, 70: 461-477. 10.1021\/np068054v.","journal-title":"J Nat Prod"},{"key":"450_CR9","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1021\/jo01128a007","volume":"20","author":"W Bergmann","year":"1955","unstructured":"Bergmann W, Burke DC: Contribution to the study of marine products. XXXIX. The nucleosides of sponges. III. 1. Spongothymidine and Spongouridine 2. J Org Chem. 1955, 20: 1501-1507. 10.1021\/jo01128a007.","journal-title":"J Org Chem"},{"key":"450_CR10","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1021\/ja01162a543","volume":"72","author":"W Bergmann","year":"1950","unstructured":"Bergmann W, Feeney RJ: The isolation of a new thymine pentoside from sponges1. J Am Chem Soc. 1950, 72: 2809-2810.","journal-title":"J Am Chem Soc"},{"key":"450_CR11","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1021\/jo01146a023","volume":"16","author":"W Bergmann","year":"1951","unstructured":"Bergmann W, Feeney RJ: Contributions to the study of marine products. XXXII. The nucleosides of sponges 1.1. J Org Chem. 1951, 16: 981-987. 10.1021\/jo01146a023.","journal-title":"J Org Chem"},{"key":"450_CR12","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.3390\/md9091580","volume":"9","author":"M Essack","year":"2011","unstructured":"Essack M, Bajic VB, Archer JA: Recently confirmed apoptosis-inducing lead compounds isolated from marine sponge of potential relevance in cancer treatment. Mar Drugs. 2011, 9: 1580-1606. 10.3390\/md9091580.","journal-title":"Mar Drugs"},{"key":"450_CR13","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1021\/np040031y","volume":"67","author":"DJ Newman","year":"2004","unstructured":"Newman DJ, Cragg GM: Marine natural products and related compounds in clinical and advanced preclinical trials. J Nat Prod. 2004, 67: 1216-1238. 10.1021\/np040031y.","journal-title":"J Nat Prod"},{"key":"450_CR14","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S0140-6736(11)60070-6","volume":"377","author":"J Cortes","year":"2011","unstructured":"Cortes J, O'Shaughnessy J, Loesch D, Blum JL, Vahdat LT, Petrakova K, Chollet P, Manikas A, Di\u00e9ras V, Delozier T: Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study. Lancet. 2011, 377: 914-923. 10.1016\/S0140-6736(11)60070-6.","journal-title":"Lancet"},{"key":"450_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.reprotox.2011.12.007","volume":"33","author":"AS Dawe","year":"2011","unstructured":"Dawe AS, Radovanovic A, Kaur M, Sagar S, Seshadri SV, Schaefer U, Kamau AA, Christoffels A, Bajic VB: DESTAF: A database of text-mined associations for reproductive toxins potentially affecting human fertility. Reprod Toxicol. 2011, 33: 99-105.","journal-title":"Reprod Toxicol"},{"key":"450_CR16","doi-asserted-by":"publisher","first-page":"D820","DOI":"10.1093\/nar\/gkn593","volume":"37","author":"M Kaur","year":"2009","unstructured":"Kaur M, Radovanovic A, Essack M, Schaefer U, Maqungo M, Kibler T, Schmeier S, Christoffels A, Narasimhan K, Choolani M, Bajic VB: Database for exploration of functional context of genes implicated in ovarian cancer. Nucleic Acids Res. 2009, 37: D820-823. 10.1093\/nar\/gkn593.","journal-title":"Nucleic Acids Res"},{"key":"450_CR17","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.meegid.2010.12.006","volume":"11","author":"SK Kwofie","year":"2011","unstructured":"Kwofie SK, Radovanovic A, Sundararajan VS, Maqungo M, Christoffels A, Bajic VB: Dragon exploratory system on hepatitis C virus (DESHCV). Infect Genet Evol. 2011, 11: 734-739. 10.1016\/j.meegid.2010.12.006.","journal-title":"Infect Genet Evol"},{"key":"450_CR18","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1186\/1471-2164-9-622","volume":"9","author":"S Sagar","year":"2008","unstructured":"Sagar S, Kaur M, Dawe A, Seshadri SV, Christoffels A, Schaefer U, Radovanovic A, Bajic VB: DDESC: Dragon database for exploration of sodium channels in human. BMC Genomics. 2008, 9: 622-10.1186\/1471-2164-9-622.","journal-title":"BMC Genomics"},{"key":"450_CR19","doi-asserted-by":"publisher","first-page":"W766","DOI":"10.1093\/nar\/gki422","volume":"33","author":"ML Hekkelman","year":"2005","unstructured":"Hekkelman ML, Vriend G: MRS: a fast and compact retrieval system for biological data. Nucleic Acids Res. 2005, 33: W766-769. 10.1093\/nar\/gki422.","journal-title":"Nucleic Acids Res"},{"key":"450_CR20","doi-asserted-by":"publisher","first-page":"W399","DOI":"10.1093\/nar\/gkn296","volume":"36","author":"D Cheng","year":"2008","unstructured":"Cheng D, Knox C, Young N, Stothard P, Damaraju S, Wishart DS: PolySearch: a web-based text mining system for extracting relationships between human diseases, genes, mutations, drugs and metabolites. Nucleic Acids Res. 2008, 36: W399-405. 10.1093\/nar\/gkn296.","journal-title":"Nucleic Acids Res"},{"key":"450_CR21","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1104\/pp.105.060863","volume":"138","author":"VB Bajic","year":"2005","unstructured":"Bajic VB, Veronika M, Veladandi PS, Meka A, Heng MW, Rajaraman K, Pan H, Swarup S: Dragon Plant Biology Explorer. A text-mining tool for integrating associations between genetic and biochemical entities with genome annotation and biochemical terms lists. Plant Physiol. 2005, 138: 1914-1925. 10.1104\/pp.105.060863.","journal-title":"Plant Physiol"},{"key":"450_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1353\/pbm.1986.0087","volume":"30","author":"DR Swanson","year":"1986","unstructured":"Swanson DR: Fish oil, Raynaud's syndrome, and undiscovered public knowledge. Perspect Biol Med. 1986, 30: 7-18.","journal-title":"Perspect Biol Med"},{"key":"450_CR23","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1016\/S0040-4020(01)89673-3","volume":"50","author":"NB Perry","year":"1994","unstructured":"Perry NB, Ettouati L, Litaudon M, Blunt JW, Munro MHG, Parkin S, Hope H: Alkaloids from the antarctic sponge\u2009<\u2009i\u2009>\u2009Kirkpatrickia varialosa<\/i\u2009>. Part 1: Variolin b, a new antitumour and antiviral compound. Tetrahedron. 1994, 50: 3987-3992. 10.1016\/S0040-4020(01)89673-3.","journal-title":"Tetrahedron"},{"key":"450_CR24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1021\/jo026508x","volume":"68","author":"P Molina","year":"2003","unstructured":"Molina P, Fresneda PM, Delgado S: Carbodiimide-mediated preparation of the tricyclic pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidine ring system and its application to the synthesis of the potent antitumoral marine alkaloid variolin B and analog. J Org Chem. 2003, 68: 489-499. 10.1021\/jo026508x.","journal-title":"J Org Chem"},{"key":"450_CR25","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1016\/j.ejca.2005.05.015","volume":"41","author":"M Simone","year":"2005","unstructured":"Simone M, Erba E, Damia G, Vikhanskaya F, Di Francesco AM, Riccardi R, Bailly C, Cuevas C, Fernandez Sousa-Faro JM, D'Incalci M: Variolin B and its derivate deoxy-variolin B: new marine natural compounds with cyclin-dependent kinase inhibitor activity. Eur J Cancer. 2005, 41: 2366-2377. 10.1016\/j.ejca.2005.05.015.","journal-title":"Eur J Cancer"},{"key":"450_CR26","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1017\/S146239941000150X","volume":"12","author":"DJ Bonda","year":"2010","unstructured":"Bonda DJ, Lee HP, Kudo W, Zhu X, Smith MA, Lee HG: Pathological implications of cell cycle re-entry in Alzheimer disease. Expert Rev Mol Med. 2010, 12: e19-","journal-title":"Expert Rev Mol Med"},{"key":"450_CR27","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/j.1460-2075.1994.tb06360.x","volume":"13","author":"T Suzuki","year":"1994","unstructured":"Suzuki T, Oishi M, Marshak DR, Czernik AJ, Nairn AC, Greengard P: Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein. EMBO J. 1994, 13: 1114-1122.","journal-title":"EMBO J"},{"key":"450_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/0014-5793(93)80849-P","volume":"336","author":"K Baumann","year":"1993","unstructured":"Baumann K, Mandelkow EM, Biernat J, Piwnica-Worms H, Mandelkow E: Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett. 1993, 336: 417-424. 10.1016\/0014-5793(93)80849-P.","journal-title":"FEBS Lett"},{"key":"450_CR29","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.bbadis.2006.11.001","volume":"1772","author":"Z Nagy","year":"2007","unstructured":"Nagy Z: The dysregulation of the cell cycle and the diagnosis of Alzheimer's disease. Biochim Biophys Acta. 2007, 1772: 402-408. 10.1016\/j.bbadis.2006.11.001.","journal-title":"Biochim Biophys Acta"},{"key":"450_CR30","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.bbadis.2006.10.014","volume":"1772","author":"X Zhu","year":"2007","unstructured":"Zhu X, Lee HG, Perry G, Smith MA: Alzheimer disease, the two-hit hypothesis: an update. Biochim Biophys Acta. 2007, 1772: 494-502. 10.1016\/j.bbadis.2006.10.014.","journal-title":"Biochim Biophys Acta"},{"key":"450_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.pharmthera.2005.09.005","volume":"111","author":"RL Neve","year":"2006","unstructured":"Neve RL, McPhie DL: The cell cycle as a therapeutic target for Alzheimer's disease. Pharmacol Ther. 2006, 111: 99-113. 10.1016\/j.pharmthera.2005.09.005.","journal-title":"Pharmacol Ther"},{"key":"450_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/ddr.20287","volume":"70","author":"MJ Savage","year":"2009","unstructured":"Savage MJ, Gingrich DE: Advances in the development of kinase inhibitor therapeutics for Alzheimer's disease. Drug Dev Res. 2009, 70: 125-144. 10.1002\/ddr.20287.","journal-title":"Drug Dev Res"},{"key":"450_CR33","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1021\/np800342s","volume":"71","author":"Y Liu","year":"2008","unstructured":"Liu Y, Liu R, Mao SC, Morgan JB, Jekabsons MB, Zhou YD, Nagle DG: Molecular-targeted antitumor agents. 19. Furospongolide from a marine Lendenfeldia sp. sponge inhibits hypoxia-inducible factor-1 activation in breast tumor cells. J Nat Prod. 2008, 71: 1854-1860. 10.1021\/np800342s.","journal-title":"J Nat Prod"},{"key":"450_CR34","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1182\/blood-2010-10-314427","volume":"117","author":"J Schodel","year":"2011","unstructured":"Schodel J, Oikonomopoulos S, Ragoussis J, Pugh CW, Ratcliffe PJ, Mole DR: High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood. 2011, 117: e207-217. 10.1182\/blood-2010-10-314427.","journal-title":"Blood"},{"key":"450_CR35","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1093\/nar\/gkp425","volume":"37","author":"Y Benita","year":"2009","unstructured":"Benita Y, Kikuchi H, Smith AD, Zhang MQ, Chung DC, Xavier RJ: An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia. Nucleic Acids Res. 2009, 37: 4587-4602. 10.1093\/nar\/gkp425.","journal-title":"Nucleic Acids Res"},{"key":"450_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1177\/1534735405282557","volume":"4","author":"CR Pradeep","year":"2005","unstructured":"Pradeep CR, Sunila ES, Kuttan G: Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies. Integr Cancer Ther. 2005, 4: 315-321. 10.1177\/1534735405282557.","journal-title":"Integr Cancer Ther"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1758-2946-5-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1758-2946-5-11\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1758-2946-5-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T22:48:00Z","timestamp":1630536480000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/1758-2946-5-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,16]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["450"],"URL":"https:\/\/doi.org\/10.1186\/1758-2946-5-11","relation":{},"ISSN":["1758-2946"],"issn-type":[{"value":"1758-2946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,16]]},"assertion":[{"value":"6 October 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"11"}}